Adicet Bio director Bastiano Sanna resigns; Katie Peng joins Audit Committee

Adicet Bio, Inc.

Bastiano Sanna resigned from Board and Audit Committee effective Nov 7, 2023; no disagreement cited.
Board size reduced from 9 to 8 members; no replacement expected for Sanna's seat.
Katie Peng appointed to Audit Committee effective Nov 7; she meets Nasdaq independence standards.
Audit Committee now comprises Steve Dubin (chair), Andrew Sinclair, and Katie Peng.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bastiano Sanna

Director

ACET · Adicet Bio, Inc.

Effective: 2023-11-07
Filed: November 13, 2023, 6:59 PM ET

On November 7, 2023 (the “Effective Date”), Bastiano Sanna, Ph.D., a current Class III member of the Board of Directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Audit Committee of the Board (“Audit Committee”), effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bastiano Sanna resigned as Director at Adicet Bio, Inc..

Action: resigned
Role: Director

Exact text from the filing

On November 7, 2023 (the “Effective Date”), Bastiano Sanna, Ph.D., a current Class III member of the Board of Directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Audit Committee of the Board (“Audit Committee”), effective as of the Effective Date.

View on SEC.gov

Adicet Bio, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-063062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.